Mayne And Mithra Receive Australian Nextstellis Approval

Launch Expected In Mid-2022 After TGA Endorses Estetrol/Drospirenone Contraceptive

 
• By Dave Wallace
  
Australian_Dollars
Mayne sees potential in the Australian contraceptive market • Source: Shutterstock

More from Value Added Medicines

More from Products